The HSE wishes to establish a national multi supplier contract for the provision of Directly Acting Antiviral (DAAs) medicines for use in provision of treatment for hepatitis C to patients across all genotypes in 2018.
The National Hepatitis C Treatment Programme (NHCTP) aims to provide treatment to every person with hepatitis C over the coming years so that it is a rare disease in Ireland by 2026. There are approximately 30 000 people in Ireland living with hepatitis C. The NHCTP was established in 2015 in response to the Department of Health Report “A Public Health Plan for the Therapeutic Treatment of Hepatitis C”. The NHCTP has received an annual budget of EUR 30 000 000 for all programme activities since 2015 and the NHCTP is currently planning treatment for 2018 within budget.
This tender process is to cover patients initiating Hepatitis C treatment up to and including 28.2.2019.
Deadline
The time limit for receipt of tenders was 2018-03-05.
The procurement was published on 2018-02-01.
Suppliers
The following suppliers are mentioned in award decisions or other procurement documents:
Object Scope of the procurement
Title:
“National Multi Supplier Contract for DAA Medicines for the National Hepatitis C Treatment Programme
HSE 9966”
Products/services: Pharmaceutical products📦
Short description:
“The HSE wishes to establish a national multi supplier contract for the provision of Directly Acting Antiviral (DAAs) medicines for use in provision of...”
Short description
The HSE wishes to establish a national multi supplier contract for the provision of Directly Acting Antiviral (DAAs) medicines for use in provision of treatment for hepatitis C to patients across all genotypes in 2018.
The National Hepatitis C Treatment Programme (NHCTP) aims to provide treatment to every person with hepatitis C over the coming years so that it is a rare disease in Ireland by 2026. There are approximately 30 000 people in Ireland living with hepatitis C. The NHCTP was established in 2015 in response to the Department of Health Report “A Public Health Plan for the Therapeutic Treatment of Hepatitis C”. The NHCTP has received an annual budget of 30 000 000 EUR for all programme activities since 2015 and the NHCTP is currently planning treatment for 2018 within budget.
This tender process is to cover patients initiating Hepatitis C treatment up to and including 28.2.2019.
Complementary information Original notice reference
Notice number in the OJ S: 2018/S 024-050522
Changes Other additional information
The closing date for receipt of tenders is changed to 10:00 on 6.3.2018
Source: OJS 2018/S 045-098370 (2018-03-04)
Contract award notice (2019-01-14) Contracting authority Information about joint procurement
The contract is awarded by a central purchasing body
Object Scope of the procurement
Short description:
“The HSE sought to establish a national multi supplier contract for the provision of Directly Acting Antiviral (DAAs) medicines for use in provision of...”
Short description
The HSE sought to establish a national multi supplier contract for the provision of Directly Acting Antiviral (DAAs) medicines for use in provision of treatment for hepatitis C to patients across all genotypes in 2018.
The National Hepatitis C Treatment Programme (NHCTP) aims to provide treatment to every person with hepatitis C over the coming years so that it is a rare disease in Ireland by 2026. There are approximately 30 000 people in Ireland living with hepatitis C. The NHCTP was established in 2015 in response to the Department of Health Report “A Public Health Plan for the Therapeutic Treatment of Hepatitis C”. The NHCTP has received an annual budget of 30 000 000 EUR for all programme activities since 2015 and the NHCTP is currently planning treatment for 2018 within budget.
This tender process is to cover patients initiating Hepatitis C treatment up to and including 28.2.2019.
Show more
Total value of the procurement (excluding VAT): EUR 30 000 000 💰
1️⃣
Additional products/services: Pharmaceutical products📦
Place of performance: Éire/Ireland🏙️
Main site or place of performance: Ireland.
Description of the procurement:
“The HSE sought to establish a national multi supplier contract for the provision of Directly Acting Antiviral (DAAs) medicines for use in provision of...”
Description of the procurement
The HSE sought to establish a national multi supplier contract for the provision of Directly Acting Antiviral (DAAs) medicines for use in provision of treatment for hepatitis C to patients across all genotypes in 2018.
The National Hepatitis C Treatment Programme (NHCTP) aims to provide treatment to every person with hepatitis C over the coming years so that it is a rare disease in Ireland by 2026. There are approximately 30 000 people in Ireland living with hepatitis C. The NHCTP was established in 2015 in response to the Department of Health Report “A Public Health Plan for the Therapeutic Treatment of Hepatitis C”. The NHCTP has received an annual budget of 30 000 000 EUR for all programme activities since 2015 and the NHCTP is currently planning treatment for 2018 within budget.
This tender process is to cover patients initiating Hepatitis C treatment up to and including 28.2.2019.
Show more Award criteria
Quality criterion (name): Quality
Quality criterion (weighting): 20 %
Quality criterion (name): Contract management
Quality criterion (weighting): 10 %
Price (weighting): 70 %
Procedure Type of procedure
Open procedure
Administrative information
Previous publication concerning this procedure: 2018/S 024-050522
Award of contract
1️⃣
Contract Number: 1
Title:
“National Multi-Supplier Contract for DAA Medicines for the National Hepatitis C Treatment Programme”
Date of conclusion of the contract: 2018-07-09 📅
Information about tenders
Number of tenders received: 3
The contract has been awarded to a group of economic operators ✅ Name and address of the contractor
Name: Gilead Sciences Ireland UC
Postal town: Carrigtohill
Country: Ireland 🇮🇪
Region: Éire/Ireland🏙️
The contractor is an SME
Name: AbbVie Ltd
Postal town: Dublin
Name: MSD Ireland (Human Health) Ltd
Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot: EUR 30 000 000 💰
Complementary information Review body
Name: The High Court
Postal address: Four Courts
Postal town: Dublin
Country: Ireland 🇮🇪
Source: OJS 2019/S 011-021173 (2019-01-14)